FDA Approves First Crispr Treatment That Might Cure Sickle Cell

The Food and Drug Administration approved a new gene editing therapy for sickle cell disease, its first green light for a Crispr treatment.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Business /business Innovation /innovation Healthcare /healthcare Science /science Breaking breaking-news topline Source Type: news